News

Filter

Current filters:

romidepsin

Cyclacel sells four disputed romidepsin-related patents to Celgene

05-04-2013

USA based Cyclacel Pharmaceuticals (Nasdaq: CYCC) says that it has entered into a definitive agreement…

BiotechnologyCelgeneCyclacel PharmaceuticalsLegalOncologyPatentsromidepsin

COMPANY SPOTLIGHT

Menarini

Back to top